These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7837)

  • 41. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
    Murad F; Waldman S; Molina C; Bennett B; Leitman D
    Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
    Wohlfart P; Malinski T; Ruetten H; Schindler U; Linz W; Schoenafinger K; Strobel H; Wiemer G
    Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cyclic guanosine monophosphate (cGMP): metabolism and its biological role].
    Fedorov NA
    Usp Sovrem Biol; 1976; 82(4):34-46. PubMed ID: 10694
    [No Abstract]   [Full Text] [Related]  

  • 44. Simultaneous measurement of endothelium-derived relaxing factor by bioassay and guanylate cyclase stimulation.
    Kondo K; Mitchell JA; de Nucci G; Vane JR
    Br J Pharmacol; 1989 Oct; 98(2):630-6. PubMed ID: 2573403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ergotamine and dihydroergotamine enhance guanylate cyclase activity.
    Vesely DL
    Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):245-54. PubMed ID: 6136069
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition by retinol and butylated hydroxyanisole of carcinogen-mediated increases in guanylate cyclase activity and guanosine 3':5'-monophosphate accumulation.
    Craven PA; DeRubertis FR
    Cancer Res; 1977 Nov; 37(11):4088-97. PubMed ID: 20225
    [No Abstract]   [Full Text] [Related]  

  • 47. Current Modulation of Guanylate Cyclase Pathway Activity-Mechanism and Clinical Implications.
    Grześk G; Nowaczyk A
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34200064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of synthesis of guanosine 3':5'-cyclic monophosphate in neuroblastoma cells.
    Bartfai T; Breakefield XO; Greengard P
    Biochem J; 1978 Oct; 176(1):119-27. PubMed ID: 31871
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Testosterone and its precursors and metabolites enhance guanylate cyclase activity.
    Vesely DL
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3491-4. PubMed ID: 40226
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of hepatic nuclear guanylate cyclase.
    Earp HS; Smith P; Huang Ong SH; Steiner AL
    Proc Natl Acad Sci U S A; 1977 Mar; 74(3):946-50. PubMed ID: 15262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of atriopeptin on particulate guanylate cyclase from rat adrenal.
    Waldman SA; Rapoport RM; Fiscus RR; Murad F
    Biochim Biophys Acta; 1985 May; 845(2):298-303. PubMed ID: 2859896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system.
    Waldman SA; Murad F
    J Cardiovasc Pharmacol; 1988; 12 Suppl 5():S115-8. PubMed ID: 2469867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Properties and oxidative regulation of guanylate cyclase.
    Mittal CK; Murad F
    J Cyclic Nucleotide Res; 1977 Dec; 3(6):381-91. PubMed ID: 24062
    [No Abstract]   [Full Text] [Related]  

  • 54. Modulation of rat guanylate cyclase activity in vitro by chemical carcinogens.
    Vesely DL; Lehotay DC; Levey GS
    Enzyme; 1978; 23(5):356-60. PubMed ID: 30621
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formation of endothelium-derived relaxing factor in porcine kidney epithelial LLC-PK1 cells: an intra- and intercellular messenger for activation of soluble guanylate cyclase.
    Ishii K; Chang B; Kerwin JF; Wagenaar FL; Huang ZJ; Murad F
    J Pharmacol Exp Ther; 1991 Jan; 256(1):38-43. PubMed ID: 1671098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of cyclic GMP levels in the ductus deferens of the rat.
    Schultz G; Hardman JG
    Adv Cyclic Nucleotide Res; 1975; 5():339-51. PubMed ID: 165675
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies on cyclic nucleotides in cancer. I. Adenylate guanylate cyclase and protein kinases in the prostatic sarcoma tissue.
    Shima S; Kawashima Y; Hirai M; Kouyama H
    Biochim Biophys Acta; 1976 Sep; 444(2):571-8. PubMed ID: 9148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
    Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of soluble guanylyl cyclase activity by oestradiol and progesterone in the hypothalamus but not hippocampus of female rats.
    Reyna-Neyra A; Sarkar G; Etgen AM
    J Neuroendocrinol; 2007 Jun; 19(6):418-25. PubMed ID: 17388815
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue guanosine-3',5'-cyclic monophosphate levels and soluble guanylate cyclase activity: a positive correlation during unilateral cryptorchidism in the rat testis.
    Spruill WA; Steiner AL; Earp HS
    J Clin Invest; 1978 Sep; 62(3):568-76. PubMed ID: 29053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.